BeStock  
Markets › Compare › CTKB vs IART

CTKB vs IART

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CTKB · Cytek Biosciences$6.12 ▼ 3.16%
IART · Integra Lifesciences$13.25 ▼ 2.21%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5180108137165Nov 24, '25May 26, '26Nov 20, '26
  • CTKB +4.8%
  • IART +6.2%

Head to head

MetricCTKBIART
Price$6.12$13.25
Change today▼ 3.16%▼ 2.21%
Market cap$800.40M$1.03B
Return, 3 months+37.8%-20.6%
Return, year to date+21.2%+6.7%
Return, 1 year+4.1%+10.0%
P/E (TTM)–77.9
P/B2.51.0
P/E percentile vs own 5y70th99th
Dividend yield––
Revenue growth (YoY, latest qtr)+1.8%+2.3%
Net profit growth (YoY)-11.3%+374.8%
Gross margin54.7%52.4%
Operating margin-21.1%4.4%
Net margin-39.1%0.8%
Return on equity-23.2%0.7%
Analyst target vs. price+18.5%+13.2%
Analyst buy share100%14%
RSI (14)5745
30-day volatility58.9%66.7%
Max drawdown, 1 year-42.9%-40.4%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • IART is the largest of the group by market value.
  • IART has returned the most over the past year.
  • IART is growing revenue fastest.
  • IART keeps the most profit per dollar of sales.
  • CTKB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top